Clinical trial · Interventional
Using Information Technology to Improve Outcomes for Children Living With Cancer
NCT04789720CI-TRIAL-00109537SyMon-SAYScompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This proposed study plans to develop and evaluate a patient-oriented, technology-based, symptom monitoring system that reports symptoms experienced by children with cancer to their parents and health care providers.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Symptom Monitoring & Systematic Assessment and Reporting System in Young Survivors (SyMon-SAYS) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- SyMon-SAYS Intervention (Group A)
- description
- Group A participants will receive the SyMon-SAYS intervention every week for 16 weeks.
- interventionNames
- Behavioral: Symptom Monitoring & Systematic Assessment and Reporting System in Young Survivors (SyMon-SAYS)
- type
- OTHER
- label
- SyMon-SAYS Waitlist Control (Group B)
- description
- The waitlist control group participants (Group B) will receive their usual care during weeks 1-8 and will receive the SyMon-SAYS intervention every week during weeks 9-16.
- interventionNames
- Behavioral: Symptom Monitoring & Systematic Assessment and Reporting System in Young Survivors (SyMon-SAYS)
Primary outcomes (5)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 8 Years
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria: Patients * Have an hematology/oncologic diagnosis (including a brain tumor) * Be on-treatment or within 6 months post-therapy * Be between 8 and 17 years old * English-speaking * Have sufficient cognitive and motor abilities to complete survey via an electronic device (e.g., smartphone, iPAD, etc.) or computer * Be able and willing to sign assent forms (for those 12-17 years old). Parent/legal guardian * Be a parent (father or mother) or a legal guardian of eligible patients * Demonstrates sufficient English and/or Spanish ability to understand and sign the informed consent form * Have sufficient cognitive and motor abilities to complete survey via an electronic device (e.g., smartphone, iPAD, etc) or computer Exclusion Criteria: * Patients who cannot understand English sufficiently to sign consent/assent form * Patients who cannot understand English sufficiently to complete the questionnaires
References
Publications (1)
- DERIVEDLai JS, Jensen SE, Peipert JD, Mitchell SA, Garcia SF, Cella D, Goldman S, Lenzen A. Using IT to Improve Outcomes for Children Living With Cancer (SyMon-SAYS): Protocol for a Single-Institution Waitlist Randomized Controlled Trial. JMIR Res Protoc. 2023 Sep 8;12:e50993. doi: 10.2196/50993. PMID 37682593